SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath ($PATH) is trending as investors discuss its potential as an AI automation play following Needham's rating update to Hold. Community members are debating the company's growth prospects, share buybacks, and potential for a short squeeze after earnings. Talk centers around agentic AI revenue and the stock's valuation relative to peers in the tech and robotics sectors.

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel.

Polyrizon Ltd.

Polyrizon Ltd. Ordinary Shares

Polyrizon ($PLRZ) is trending due to promising results for its intranasal naloxone hydrogel, sparking significant after-hours momentum. The community is actively discussing the potential for a short squeeze reminiscent of other Israeli momentum stocks, while some traders are wary of potential dilution. With a low float, the stock is exhibiting high volatility, leading to speculation about potential price targets and comparisons to past high-flying stocks.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is trending following its earnings report, with initial positive reactions tempered by concerns about future performance and AI disruption; the community is actively debating whether the company's growth justifies its valuation and if its AI strategy is strong enough. Some investors express skepticism, citing a lack of trust in leadership and concerns about the company's ability to adapt to the evolving tech landscape, while others remain optimistic about its long-term potential.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Bozeman, MT.

Snowflake Inc

Snowflake is trending after announcing a partnership with Palantir to integrate their AI platforms, with analysts suggesting the company is well-positioned to capitalize on AI demand. The community is discussing the potential impact of this partnership, particularly on Snowflake's data cloud and its competitive positioning against other cloud service providers. Despite a YTD surge, some are questioning the valuation and profitability.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth ($USAR) is trending due to a newly announced supply agreement between its subsidiary, Less Common Metals, and Solvay and Arnold Magnetic Technologies to supply rare earth metals. The community is discussing the significance of this agreement for rare earth independence and potential government support, while also debating the stock's volatility and comparing it to competitors.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

The SPDR Dow Jones Industrial Average ETF ($DIA) is trending amid speculation about a potential Fed rate cut in December, fueled by dovish comments from Fed officials and recent economic data. Community members are debating whether this rally is sustainable or if it's a bull trap before a deeper correction, with some pointing to oversold conditions in tech and potential rotation into value stocks. Discussions also involve the impact of economic data, upcoming announcements, and technical analysis on the ETF's price movement.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending as investors discuss its expansion into Canada and the potential impact on revenue, along with its recent acquisition of YourBio Health. Community members are debating whether these developments will drive the stock price higher or if it will face continued pressure from short sellers. Some see the company as undervalued, while others express concern about its ability to break through resistance levels.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure ($QURE) is trending due to FDA feedback regarding its Huntington's disease gene therapy, with the agency indicating that Phase I/II data is unlikely to be sufficient for approval. The community is actively discussing the implications of this decision, including potential delays and the need for further clinical trials, alongside skepticism towards management. Some traders are weighing the long-term potential against the immediate regulatory challenges, with a few hoping for a reversal or buyout.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

The Global X Dow 30 Covered Call ETF ($DJIA) is trending amid discussions about market momentum and potential short squeezes in related stocks like $KALA. Some traders are highlighting call options and anticipating further upside, while others suggest caution due to overbought conditions and potential market corrections. The ETF's movements are also being analyzed in relation to broader market indices like $SPX and $QQQ.

Dollar General Corp. engages in the operation of merchandise stores. Its offerings include food, snacks, health and beauty aids, cleaning supplies, basic apparel, housewares, and seasonal items. It sells brands including Clorox, Energizer, Procter & Gamble, Hanes, Coca-Cola, Mars, Unilever, Nestle, Kimberly-Clark, Kellogg's, General Mills, and PepsiCo. The company was founded by J. L. Turner and Hurley Calister Turner Sr. in 1939 and is headquartered in Goodlettsville, TN.

Dollar General Corp.

Dollar General's recent earnings beat and raised fiscal year guidance have sparked community discussion around the stock's potential. While some investors express frustration with its past performance compared to tech stocks, others point to its value proposition and resilience in a challenging economic environment, especially with strategic initiatives like store remodels and digital upgrades. Broader context includes commentary around consumer spending habits and how tariff impacts could level the playing field for discount retailers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Prudential Financial Inc. Purchases 48,055 Shares of Akero Therapeutics, Inc. $AKRO

Prudential Financial Inc. raised its position in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO - Free Report) by 125.0% in the 2nd quarter, according to the company in its most recent disclosure...

Loomis Sayles & Co. L P Acquires 51,850 Shares of Akero Therapeutics, Inc. $AKRO

Loomis Sayles & Co. L P raised its holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO - Free Report) by 10.6% during the 2nd quarter, according to the company in its most recent filing with the...

F m Investments LLC Has $960,000 Holdings in Akero Therapeutics, Inc. $AKRO

F m Investments LLC cut its holdings in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO - Free Report) by 37.1% during the 2nd quarter, according to the company in its most recent disclosure with the...

7,107 Shares in Akero Therapeutics, Inc. $AKRO Bought by DLD Asset Management LP

DLD Asset Management LP bought a new stake in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and...

Foresite Capital Management VI LLC Has $13.07 Million Stock Holdings in Akero Therapeutics, Inc. $AKRO

Foresite Capital Management VI LLC lessened its position in Akero Therapeutics, Inc. (NASDAQ:AKRO - Free Report) by 32.9% during the 2nd quarter, according to its most recent filing with the...

Ensign Peak Advisors Inc Has $10.05 Million Holdings in Akero Therapeutics, Inc. $AKRO

Ensign Peak Advisors Inc lifted its position in Akero Therapeutics, Inc. (NASDAQ:AKRO - Free Report) by 21.5% in the 2nd quarter, according to the company in its most recent filing with the SEC. The...

Intech Investment Management LLC Sells 16,635 Shares of Akero Therapeutics, Inc. $AKRO

Intech Investment Management LLC lowered its position in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO - Free Report) by 28.4% in the second quarter, according to the company in its most recent...

Akero Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akero Therapeutics, Inc. - AKRO

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Akero Therapeutics, Inc. (NasdaqGS: AKRO) to...

Bank of New York Mellon Corp Increases Stake in Akero Therapeutics, Inc. $AKRO

Bank of New York Mellon Corp increased its stake in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO - Free Report) by 11.8% during the second quarter, according to its most recent Form 13F filing...

Halper Sadeh LLC Encourages WOW, AKRO, HFWA, BRY Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC Encourages WOW, AKRO, HFWA, BRY Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages WOW, AKRO, HFWA, BRY Shareholders to Contact the Firm to Discuss...

Akero Therapeutics, Inc. is a clinical-stage company, which engages in the development of treatments for patients with serious metabolic diseases. The firm's lead product candidate, efruxifermin (EFX), is an analog of fibroblast growth factor 21, or FGF21, which is an endogenously expressed hormone that protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. The company was founded by Jonathan Young and Timothy Rolph in January 2017 and is headquartered in South San Francisco, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$1.00	--	--	N/A
Q3 '25	-$0.96	--	--	N/A
Q2 '25	-$0.92	-$0.86	6.23%	BEAT
Q1 '25	-$0.96	-$0.90	6.18%	BEAT
Q4 '24	-$1.16	-$0.99	14.75%	BEAT

AKRO
Akero Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest AKRO News

AKROAkero Therapeutics Inc